(S)-10-chloro-1-(3-ethoxypyrrolidine-1-carbonyl)-3-phenyl-6,7-dihydro-4H-pyrido[2,1-a]isoquinolin-4-one

Catalog No. :
ACHDAS922
CAS No. :
143943-73-1
Molecular Formula :
C26H25ClN2O3
Molecular Weight :
448.95

IUPAC Name:(S)-10-chloro-1-(3-ethoxypyrrolidine-1-carbonyl)-3-phenyl-6,7-dihydro-4H-pyrido[2,1-a]isoquinolin-4-one

(S)-10-chloro-1-(3-ethoxypyrrolidine-1-carbonyl)-3-phenyl-6,7-dihydro-4H-pyrido[2,1-a]isoquinolin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-10-chloro-1-(3-ethoxypyrrolidine-1-carbonyl)-3-phenyl-6,7-dihydro-4H-pyrido[2,1-a]isoquinolin-4-one
IUPAC Name(S)-10-chloro-1-(3-ethoxypyrrolidine-1-carbonyl)-3-phenyl-6,7-dihydro-4H-pyrido[2,1-a]isoquinolin-4-one
Molecular FormulaC26H25ClN2O3
Molecular Weight448.95
SMILESCCO[C@H]1CCN(C(=O)C2=C3C4=C(C=CC(Cl)=C4)CCN3C(=O)C(C3=CC=CC=C3)=C2)C1
InChI KeyCBSWRAUYCIIUEI-FQEVSTJZSA-N
SynonymLirequinil;Lirequinil [inn];Unii-2vuw1087ad;10-chloro-1-[(3S)-3-ethoxypyrrolidine-1-carbonyl]-3-phenyl-6,7-dihydrobenzo[a]quinolizin-4-one;4H-Benzo[a]quinolizin-4-one, 10-chloro-1-[[(3S)-3-ethoxy-1-pyrrolidinyl]carbonyl]-6,7-dihydro-3-phenyl-
CAS No.143943-73-1

Synthetic Route by SureRoute

1. ACHDAS922 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLJYS783 route compound structure diagram
    ACLJYS783164790-65-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHDAS922 route product structure diagram
    ACHDAS922143943-73-1
Inquiry

2. ACHDAS922 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHDAS922 route product structure diagram
    ACHDAS922143943-73-1
Inquiry

Comments (0)